相关实验视频

Updated: Jul 11, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

GCGACNN:一个图形神经网络和随机森林,用于预测微生物与药物之间的关联

Shujuan Su¹, Meiling Liu¹, Jiyun Zhou²

¹College of Computer and Control Engineering, Northeast Forestry University, Harbin 150040, China.

|August 29, 2024

概括

这项研究介绍了GCGACNN,这是一种预测微生物与药物相互作用的新型模型. GCGACNN准确预测微生物群落如何影响药物疗效和耐药性,超过现有方法.

科学领域:

微生物学微生物学
药理学药理学是指药理学的学科.
计算生物学计算生物学

背景情况:

微生物与药物的相互作用影响药物的疗效,耐药性和宿主代谢.
了解这些相互作用对于药物开发和治疗策略至关重要.
耐药性基因和微生物群落在这些复杂的关系中起着关键作用.

研究的目的:

开发一种新的预测模型,GCGACNN,用于微生物与药物相互作用.
准确预测微生物群落对药物疗效和耐药性的影响.
建立一个有效的计算框架来分析微生物与药物之间的关联.

主要方法:

从数据库和文献中收集了微生物,疾病和药物关联数据.
使用高斯相似函数构建关联和相似特征矩阵.
采用多层图形神经网络和2D卷积神经网络用于特征提取和融合.

主要成果:

拟议的GCGACNN模型显示出卓越的预测性能.
实验结果验证了GCGACNN框架的有效性.
GCGACNN准确地捕获了复杂的微生物与药物相互作用模式.

结论:

GCGACNN在预测微生物与药物相互作用方面取得了重大进展.
该模型为了解药物有效性和耐药性演变提供了一个强大的工具.
这个框架可以帮助个性化医疗和新药发现.

关键词:

图表注意力网络图表注意力网络图表卷积网络卷积网络微生物药物协会这是一个二维卷积神经网络.

更多相关视频

Divergence of Root Microbiota in Different Habitats based on Weighted Correlation Networks

Divergence of Root Microbiota in Different Habitats based on Weighted Correlation Networks

Published on: September 25, 2021

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

相关概念视频

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...